Breaking News Instant updates and real-time market news.

KNSL

Kinsale Capital Group

$98.81

3.74 (3.93%)

, JRVR

James River Group

$37.41

0.79 (2.16%)

07:01
11/26/19
11/26
07:01
11/26/19
07:01

Kinsale Capital Group price target raised to $110 from $100 at SunTrust

SunTrust analyst Mark Hughes raised his price target on Kinsale Capital Group (KNSL) to $110 and kept his Buy rating, saying the latest set of pricing information from broker USI Insurance Services indicates acceleration in the back half of 2019 with further increases expected in 2020. The analyst adds that the company, along with James River (JRVR), have less exposure in the "excess layers" that cover larger losses and should benefit from this trend.

KNSL

Kinsale Capital Group

$98.81

3.74 (3.93%)

JRVR

James River Group

$37.41

0.79 (2.16%)

  • 03

    Dec

  • 04

    Dec

  • 09

    Dec

KNSL Kinsale Capital Group
$98.81

3.74 (3.93%)

02/25/19
RHCO
02/25/19
NO CHANGE
Target $75
RHCO
Buy
Kinsale Capital Group price target raised to $75 from $66 at SunTrust
SunTrust analyst Mark Hughes raised his price target on Kinsale Capital Group to $75 and kept his Buy rating after its Q4 earnings beat, also raising his FY19 EPS view to $2.24 from $2.10. The analyst cites the company's "continuing acceleration" in revenue growth and further opportunity in the E&S market, saying it is an "attractive stock" for investors in search of high quality financials. Hughes further notes that he assumes a 13% gross written premium growth this year in his model but also believes that these figures could "prove conservative in light of the robust submission activity at the company and favorable industry dynamics."
07/01/19
RHCO
07/01/19
NO CHANGE
Target $100
RHCO
Buy
Kinsale Capital Group price target raised to $100 from $85 at SunTrust
SunTrust analyst Mark Hughes raised his price target for Kinsale Capital Group to $100 from $85 and maintained a Buy rating following a trip with CEO Mike Kehoe to visit investors in Detroit and Southern California. In a research note to investors, Hughes says there was considerable discussion around sustainability of growth, as well as the stock valuation.
09/06/19
JMPS
09/06/19
INITIATION
JMPS
Market Perform
Kinsale Capital Group initiated with a Market Perform at JMP Securities
JMP Securities analyst Matthew Carletti initiated Kinsale Capital Group with a Market Perform rating, saying its excess & surplus lines, or E&S, insurance is in a market that is experiencing "significant growth and strong pricing increases in response to recent turmoil". The analyst points to the company's "best-in-class combined ratios and ROEs" and anticipates continued attractive growth opportunities, but also notes its premium valuation, with the stock trading at 7.1-times book value vs. the peer group average multiple of 2.5-times.
09/26/19
UBSW
09/26/19
NO CHANGE
Target $112
UBSW
Buy
Kinsale Capital Group price target raised to $112 from $98 at UBS
UBS analyst Mark Dwelle raised his price target on Kinsale Capital Group to $112 and kept his Buy rating after holding meetings with its management. The analyst says the tone of the discussions was positive, reflecting the company's confidence in delivering combined ratios in mid-80s and ROE of 15%. Dwelle adds that most of Kinsale's "broad based growth" has been "organic new business" supported by the 20% increase in submissions.
JRVR James River Group
$37.41

0.79 (2.16%)

10/09/19
RHCO
10/09/19
DOWNGRADE
Target $40
RHCO
Hold
James River Group downgraded to Hold from Buy at SunTrust
SunTrust analyst Mark Hughes downgraded James River Group to Hold from Buy with a price target of $40, down from $55.
10/09/19
10/09/19
DOWNGRADE
Target $40

Hold
James River Group downgraded to Hold from Buy at SunTrust
As previously reported, SunTrust analyst Mark Hughes downgraded James River Group (JRVR) to Hold and lowered his price target to $40 from $55 after the company's announcement that it will increase its reserves by up to $60M this quarter to account for commercial auto line of business losses as well as its ended Uber (UBER) relationship this year. As Uber reserves continue to develop adversely, the analyst is also lowering his FY20 EPS view on James River to $1.35 from $3.00, reflecting new assumptions about the company's profitability.
10/09/19
RILY
10/09/19
DOWNGRADE
Target $40
RILY
Sell
B. Riley FBR downgrades James River Group to Sell on Uber termination
James River Group Holdings (JRVR) disclosed last night that it plans to cancel all policies issued to its largest customer, Uber (UBER) commercial auto business Raiser LLC, effective December 31, 2019, due to unfavorable loss experience, B. Riley FBR analyst Randy Binner tells investors in a research note. While the reserve charge is manageable, concern around reserve adequacy is likely to remain an overhang on James River shares given the termination of the Uber relationship, a "significant move," says Binner. The analyst believes James River shares "will re-rate to a lower multiple to book value." He downgraded the stock to Sell from Neutral and cut his price target for the shares to $40 from $45.
10/10/19
BOFA
10/10/19
NO CHANGE
Target $53
BOFA
Buy
James River cancellation negative for Uber 'on the surface,' says BofA/Merrill
BofA/Merrill analyst Justin Post says James River Group (JRVR) ending early its insurance policies issued to Rasier LLC, a subsidiary of Uber Technologies (UBER), is a negative for Uber "on the surface." James River insures Uber drivers in 20 states and was the smallest of the four insurers that Uber works with in the U.S., Post tells investors in a research note. The news is a negative given the potential that the underwriting costs of Uber's business are proving to be higher than expected, says Post. However, the analyst does not anticipate a material change in Uber's insurance costs. Uber's business will likely switch to one of its other carriers, Farmers, Progressive (PGR) or Allstate (ALL), according to Post. Those three insurers are likely increasing their interest in and exposure to ridesharing and gig-economy insurance, increasingly competing for business, says Post, who thinks this could maintain or decrease gig-economy and rideshare insurance premiums over time. The analyst keeps a Buy rating on Uber with a $53 price target.

TODAY'S FREE FLY STORIES

MTN

Vail Resorts

$230.82

-1.91 (-0.82%)

16:03
12/09/19
12/09
16:03
12/09/19
16:03
Hot Stocks
Vail Resorts backs FY20 Resort Reported EBITDA guidance »

Commenting on fiscal 2020…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

SCYX

Scynexis

$0.97

0.0034 (0.35%)

16:03
12/09/19
12/09
16:03
12/09/19
16:03
Syndicate
Scynexis files to sell common stock, warrants, no amount given »

H.C. Wainwright & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDAY

Workday

$163.81

-2.5 (-1.50%)

16:02
12/09/19
12/09
16:02
12/09/19
16:02
Hot Stocks
Workday completes acquisition of Scout RFP »

Workday has completed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTN

Vail Resorts

$230.68

-2.05 (-0.88%)

16:02
12/09/19
12/09
16:02
12/09/19
16:02
Earnings
Vail Resorts reports Q1 EPS ($2.64), consensus ($2.98) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

JJSF

J & J Snack Foods

$185.55

-3.43 (-1.82%)

16:01
12/09/19
12/09
16:01
12/09/19
16:01
Hot Stocks
J & J Snack Foods increases quarterly dividend 15% »

J & J Snack Foods…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LSCC

Lattice Semiconductor

$19.03

-0.075 (-0.39%)

15:52
12/09/19
12/09
15:52
12/09/19
15:52
Conference/Events
Lattice Semiconductor to hold a launch event »

Launch event will be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

CCJ

Cameco

$9.15

-0.625 (-6.39%)

15:45
12/09/19
12/09
15:45
12/09/19
15:45
Options
Cameco call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$14.33

-0.415 (-2.82%)

15:42
12/09/19
12/09
15:42
12/09/19
15:42
Periodicals
Snapchat feature to allow users to 'deepfake you into GIFs,' Tech Crunch says »

Tech Crunch's Josh…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$342.06

6.21 (1.85%)

15:35
12/09/19
12/09
15:35
12/09/19
15:35
Hot Stocks
Senator Markey says Tesla Autopilot 'can't be allowed' to replace drivers »

U.S. Senator Ed Markey, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 07

    Jan

CASY

Casey's General Stores

$175.80

(0.00%)

15:34
12/09/19
12/09
15:34
12/09/19
15:34
Options
Caseys General Stores options imply 8.0% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

MSFT

Microsoft

$151.60

-0.17 (-0.11%)

15:33
12/09/19
12/09
15:33
12/09/19
15:33
Hot Stocks
Microsoft to shut down Wunderlist on May 6, 2020 »

Microsoft said in a blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

AQST

Aquestive Therapeutics

$7.89

-0.13 (-1.62%)

15:25
12/09/19
12/09
15:25
12/09/19
15:25
Conference/Events
Aquestive Therapeutics holds analyst & investor event w/conference call hookup »

Management and Key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

PTLA

Portola Pharmaceuticals

$28.48

-0.74 (-2.53%)

15:24
12/09/19
12/09
15:24
12/09/19
15:24
Hot Stocks
Portola presents new interim Phase 2a data from study of cerdulatinib »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARQL

ArQule

$19.72

10.045 (103.88%)

15:21
12/09/19
12/09
15:21
12/09/19
15:21
Downgrade
ArQule rating change  »

ArQule downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

TOL

Toll Brothers

$41.50

0.62 (1.52%)

15:19
12/09/19
12/09
15:19
12/09/19
15:19
Options
Toll Brothers options imply 8.6% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
12/09/19
12/09
15:17
12/09/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
12/09/19
12/09
15:16
12/09/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DISH

Dish

$33.53

-0.06 (-0.18%)

15:15
12/09/19
12/09
15:15
12/09/19
15:15
Options
Dish put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGNX

MacroGenics

$9.87

0.19 (1.96%)

15:09
12/09/19
12/09
15:09
12/09/19
15:09
Hot Stocks
MacroGenics announces updated results from Phase 1/2 study of flotetuzumab »

MacroGenics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

MDB

MongoDB

$131.13

-0.09 (-0.07%)

15:04
12/09/19
12/09
15:04
12/09/19
15:04
Options
MongoDB options imply 14.8% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 18

    Dec

IMGN

ImmunoGen

$4.06

0.195 (5.05%)

15:03
12/09/19
12/09
15:03
12/09/19
15:03
Hot Stocks
ImmunoGen presents updated findings from Phase 1 study of IMGN632 at ASH meeting »

ImmunoGen announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:00
12/09/19
12/09
15:00
12/09/19
15:00
General news
U.S.-China trade/tariff uncertainty is still present »

U.S.-China trade/tariff…

NVS

Novartis

$92.68

0.6 (0.65%)

14:53
12/09/19
12/09
14:53
12/09/19
14:53
Hot Stocks
Novartis says Kymriah demonstrates consistent efficacy, safety outcomes »

Novartis announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

GILD

Gilead

$67.11

0.02 (0.03%)

14:51
12/09/19
12/09
14:51
12/09/19
14:51
Hot Stocks
Gilead's Kite says results ZUMA-2 trial support regulatory filings »

Kite, a Gilead company,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMDA

Gamida Cell

$5.10

0.01 (0.20%)

14:49
12/09/19
12/09
14:49
12/09/19
14:49
Hot Stocks
Gamida Cell announces results from Phase 1 clinical study of GDA-201 »

Gamida Cell announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.